Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

LIDOCAINE-PF- 5% (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

LEVEMIR-STS- 100U/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

KETAMINE 50MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HYDROXOCOBALAMIN-PF- 1MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

HEPARIN/LIDO HCL/SODIUM BICARB 100U/2MG/16.8MG/ML (20ML SYRINGE) IRRIGATION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 31%(V/V)/0.17%/0.00017% (10ML VIALS); GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 48.7%(W/V)/0.67%/0.00067% (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL, Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

GLYCERIN 72% (W/V) (15ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

FLURBIPROFEN -CORN OIL- 0.04% (3ML DROPTAINER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Ethyl Alcohol 95% (5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

ESTRADIOL CYP/TEST CYP- SS OIL- 2MG/50MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP/TEST CYP -SS OIL- 2MG/25MG/ML (1ML VIAL) INJECTABLE; ESTRADIOL CYP-CS OIL- 5MG/ML (1.25ML VIAL) INJECTABLE; ESTRADIOL CYP-GS OIL- 5MG/ML (1ML VIAL) INJECTABLE ESTRADIOL CYP-SS OIL- 5MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP-SS OIL- 5MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Estradiol 0.05% OPH Solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

EDETATE DISODIUM (VET) 1% (3ML droptainer) OPH Solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Edetate Calcium Disodium 400MG/ML (30ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Dexpanthenol/Pyridoxine/Hydroxocobalamin-PF- 250MG/100MG/1MG/ML (1ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

DEXAMETHASONE 16MG/ML (3ML VIAL) INJECTABLE; DEXAMETHASONE 24MG/ML INJECTABLE; DEXAMETHASONE-PF- 0.1% (1ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Cyclosporine (A) 0.1%; Cyclosporine (A) 0.2%; Cyclosporine (A) 1%; Cyclosporine (A) 2%; Cyclosporine (A) - Corn oil - 1% Oph solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Clindamycin/EDTA Calcium 4.1667MG/0.333MG/ML (30ML syringe) Irrigation, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Cholecalciferol (Vitamin D3) 100,000U/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Ceftazidime Intravitreal (1ML vial) 22.5 MG/ML(2.25MG/0.1ML) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Recall initiated: December 22, 2022
Reported by FDA: February 1, 2023
Distribution: Nationwide in the USA

View recall →

Data last updated: September 12, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.